Answers are grounded in this paper and cite their sources.
A December 2014 meeting reviewed Ebola virus immunology relevant to vaccine development, including Ebola prevention, immunity, assay standardization, and regulatory considerations. Vaccinated humans appear to achieve immune responses comparable in magnitude with those associated with protection in nonhuman primates, suggesting that immunological data could be used to demonstrate vaccine efficacy.
No takes yet. Share an insight, caveat, or question.
Krause et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: